Certolizumab pegol
(Synonyms:(2S)-1-((2S)-6-氨基-2-((羟基(4-苯基丁基)膦)氧基)己酰基)吡咯烷-2-羧酸;赛妥珠单抗)
目录号 : KM24251
CAS No. : 428863-50-7
纯度 : 98%
Certolizumab pegol (Certolizumab) is a recombinant, polyethylene glycolylated, antigen-binding fragment of a humanized monoclonal antibody that selectively targets and neutralizes tumour necrosis factor-α (TNF-α). Certolizumab pegol can be used for rheumatoid arthritis and Crohn disease research.
Other Forms of Rapamycin:
KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
KKL 顾客使用本产品发表的 0 篇科研文献
暂无科研文献
生物活性 |
Certolizumab pegol (Certolizumab) is a recombinant, polyethylene glycolylated, antigen-binding fragment of a humanized monoclonal antibody that selectively targets and neutralizes tumour necrosis factor-α (TNF-α). Certolizumab pegol can be used for rheumatoid arthritis and Crohn disease research.
|
分子式 |
C24H22F3N
|
分子量 |
381.433396816254
|
CAS号 |
428863-50-7
|
中文名称 |
(2S)-1-((2S)-6-氨基-2-((羟基(4-苯基丁基)膦)氧基)己酰基)吡咯烷-2-羧酸
|
运输条件 |
Room temperature in continental US; may vary elsewhere.
|
储存方式 |
Store at -20˚C
|